Response to the comments on “Acute psychosis induced by mRNA-based COVID-19 vaccine in adolescents”

Response to the comments on “Acute psychosis induced by mRNA-based COVID-19 vaccine in adolescents”

Bibliographic Details
Main Authors:	Yeh-Li Lien, Jao-Shwann Liang
Format:	Article
Language:	English
Published:	Elsevier 2023-11-01
Series:	Pediatrics and Neonatology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1875957223001006

Similar Items

Acute psychosis induced by mRNA-based COVID-19 vaccine in adolescents: A pediatric case report
by: Yeh-Li Lien, et al.
Published: (2023-05-01)

“Acute psychosis induced by mRNA-based COVID-19 vaccine in adolescents: A pediatric case report”: Comment
by: Amnuay Kleebayoon, et al.
Published: (2023-11-01)

Refractoy psychosis after mRNA COVID-19 vaccine
by: Mariel Vendramel Neves, et al.
Published: (2023-02-01)

Comment on "Reactogenicity Study of mRNA COVID-19 Vaccine"
by: Amnuay Kleebayoon, et al.
Published: (2023-07-01)

Acute Mild Pancreatitis Following COVID-19 mRNA Vaccine in an Adolescent
by: Ahmad Kantar, et al.
Published: (2021-12-01)

Myocarditis following COVID‐19 mRNA (mRNA‐1273) vaccination
by: Suresh Babu Chellapandian, et al.
Published: (2022-04-01)

Multi-epitope mRNA vaccine candidate to combat HMPV virus: Comment
by: Hinpetch Daungsupawong, et al.
Published: (2024-12-01)

mRNA as a Therapeutics: Understanding mRNA Vaccines
by: Ferdi Oğuz, et al.
Published: (2022-03-01)

Two adolescent cases of acute tubulointerstitial nephritis after second dose of COVID-19 mRNA vaccine
by: Jae Hong Choi, et al.
Published: (2022-11-01)

Excipients and mRNA vaccines
by: Shireesh Apte
Published: (2020-12-01)

mRNA-Based Vaccines
by: Frank Kowalzik, et al.
Published: (2021-04-01)

The History of mRNA Vaccine
by: Maham Akhlaq
Published: (2021-06-01)

Dangers of mRNA vaccines
by: Tahoora Ali, et al.
Published: (2021-01-01)

Levetiracetam-Induced Acute Psychosis in an Adolescent
by: Omkar Dhungel, et al.
Published: (2023-01-01)

Reactogenicity to the mRNA-1273 Booster According to Previous mRNA COVID-19 Vaccination
by: Oleguer Parés-Badell, et al.
Published: (2022-07-01)

Myocarditis and COVID-19 mRNA vaccination
by: Rujittika Mungmunpuntipantip, et al.
Published: (2022-08-01)

Commentary of the mRNA vaccines COVID-19
by: Antonio Vitiello, et al.
Published: (2021-09-01)

COVID-19 mRNA Vaccine and Myocarditis
by: Balraj Singh, et al.
Published: (2021-06-01)

Development and Delivery Systems of mRNA Vaccines
by: Yongjun Liang, et al.
Published: (2021-07-01)

Heterologous mRNA-based COVID-19 booster strategies: Comment
by: Sora Yasri, et al.
Published: (2023-01-01)

Acute Myocarditis Following Vaccination With the First Dose of the mRNA-1273 Vaccine
by: Abdulbaril Olagunju MD, et al.
Published: (2022-04-01)

mRNA vaccines in disease prevention and treatment
by: Gang Zhang, et al.
Published: (2023-09-01)

mRNA or ChAd0x1 COVID-19 Vaccination of Adolescents Induces Robust Antibody and Cellular Responses With Continued Recognition of Omicron Following mRNA-1273
by: Alexander C. Dowell, et al.
Published: (2022-06-01)

Research Advances on the Stability of mRNA Vaccines
by: Feiran Cheng, et al.
Published: (2023-03-01)

mRNA vaccines induce rapid antibody responses in mice
by: Makda S. Gebre, et al.
Published: (2022-08-01)

mRNA Vaccines against Flaviviruses
by: Clayton J. Wollner, et al.
Published: (2021-02-01)

Recent Updates on mRNA Vaccines
by: Emily Sydow, et al.
Published: (2022-07-01)

The Delivery of mRNA Vaccines for Therapeutics
by: Nitika, et al.
Published: (2022-08-01)

mRNA Innovates the Vaccine Field
by: Norbert Pardi
Published: (2021-05-01)

Neo-Antigen mRNA Vaccines
by: Arthur Esprit, et al.
Published: (2020-12-01)

The advances of adjuvants in mRNA vaccines
by: Chunyuan Xie, et al.
Published: (2023-10-01)

Progress and challenges of mRNA vaccines
by: Liangru Lin, et al.
Published: (2023-01-01)

mRNA vaccines for cancer immunotherapy
by: Yashavantha L. Vishweshwaraiah, et al.
Published: (2022-12-01)

Acute myocarditis after the third dose of COVID‐19 mRNA‐1273 vaccine
by: Takayuki Yamada
Published: (2023-05-01)

Nanotechnology-Enabled COVID-19 mRNA Vaccines
by: Yu Gao, et al.
Published: (2021-08-01)

Advances in COVID-19 mRNA vaccine development
by: Enyue Fang, et al.
Published: (2022-03-01)

Post-mRNA COVID-19 Vaccination Myocarditis
by: Abhishek Matta, et al.
Published: (2021-08-01)

Cardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents
by: Suyanee Mansanguan, et al.
Published: (2022-08-01)

Immunogenicity of an mRNA-Based COVID-19 Vaccine among Adolescents with Obesity or Liver Transplants
by: Chomchanat Tubjaroen, et al.
Published: (2022-11-01)

Hypertensive crisis following mRNA COVID-19 vaccination in adolescents: two case reports
by: Myung Hyun Cho, et al.
Published: (2022-12-01)